跳至主要内容
临床试验/NCT01723124
NCT01723124终止不适用

Comparison of Breast Cancer Detection Rate for Prevalent Screen Low-dose Molecular Breast Imaging and Incident Biennial Screen Low-dose Molecular Breast Imaging in Women With Mammographically Dense Breasts

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 228 人开始时间: 2012年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
Mayo Clinic
入组人数
228
试验地点
1
主要终点
Molecular Breast Imaging (MBI) scan

研究概览

简要总结

The purpose of this research is to evaluate whether repeating a screening Molecular Breast Imaging (MBI) study two years after an initial screening MBI study further improves breast cancer detection in women with dense breast tissue.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
Single (Investigator)

入排标准

年龄范围
40 Years 至 80 Years(Adult, Older Adult)
性别
Female
接受健康志愿者
是

入选标准

  • •- Past prior screening mammogram within the previous 11-24 months interpreted as heterogeneously dense or extremely dense and negative or benign [Breast Imaging Reporting and Data System (BI-RADS) Category 1 or 2]

排除标准

  • •Subjects will be excluded if they:
  • •Are unable to understand and sign the consent form
  • •Are pregnant or lactating
  • •Are physically unable to sit upright and still for 40 minutes
  • •Have self-reported signs or symptoms that may suggest breast cancer (palpable mass, bloody nipple discharge, axillary mass, etc.)
  • •Have had needle biopsy within 3 months, or breast surgery or radiation within 1 year prior to the study
  • •Are currently receiving chemotherapy or tamoxifen, raloxifene, or an aromatase inhibitor for adjuvant therapy or chemoprevention
  • •Have undergone bilateral mastectomy
  • •Have had a prior MBI within 20 months of scheduled study MBI.

研究组 & 干预措施

Molecular Breast Imaging

Experimental

Molecular Breast Imaging (MBI) utilizes small high resolution gamma camera detectors in a dual-detector configuration to image the breast following the administration of a radiopharmaceutical that accumulates preferentially in breast tumors.

干预措施: Molecular Breast Imaging (Procedure)

结局指标

主要结局

Molecular Breast Imaging (MBI) scan

时间窗: Performed at Year 0 of study

The Year 0 MBI will be interpreted in isolation, with the radiologist blinded to Year 0 mammogram results and all relevant clinical information.

次要结局

  • Molecular Breast Imaging (MBI) scan(Performed at Year 2 of study)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Deborah Rhodes

MD

Mayo Clinic

研究点 (1)

Loading locations...

相似试验